Obesity, diabetes treatments fuel Eli Lilly growth and spark bidding war

The market for obesity and diabetes treatments remains scorching hot, funneling billions in sales to Eli Lilly and spawning a ...

Eli Lilly raises forecasts on surging demand for weight-loss, diabetes drugs

Eli Lilly raised its full-year profit and revenue forecasts on Thursday as strong appetite for its widely popular weight-loss ...
TipRanks on MSN

Eli Lilly’s New Study: Potential Breakthrough in Type 1 Diabetes Prevention

Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. Study Overview: Eli Lilly and Company is ...
STAT

Eli Lilly’s weight loss and diabetes drug tops Keytruda as world’s best-selling medicine

Merck, which has claimed bragging rights as the maker of the world’s best-selling drug, Keytruda, since 2023, has officially ...

Eli Lilly, Novo Nordisk Stocks Rise on Reported $149 Obesity Drug Deal with White House

Eli Lilly and Company (NYSE:LLY) shares are trading slightly lower on Tuesday after its previous gains following reports ...

Lilly, Novo near White House deals to cut obesity drug prices, gain Medicare access, source says

Eli Lilly and Novo Nordisk are expected to announce deals with the Trump administration to cut prices of their weight-loss drugs in exchange for Medicare coverage, a White House source told Reuters on ...
Barron's

A Major Eli Lilly Shareholder Has Sold Stock Nearly Every Day in October. Here’s Who It Is.

A nonprofit founded by members of the Lilly family has been unloading Eli Lilly stock nearly every day since the start of the month.